Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cystitis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    57 result(s) found for: Cystitis. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2008-006559-27 Sponsor Protocol Number: OMALI2008 Start Date*: 2009-01-27
    Sponsor Name:OSPEDALE POLICLINICO S. MATTEO
    Full Title: Exploratory study on Omalizumab in patients affected by Painful Bladder Syndrome
    Medical condition: Painful bladder syndrome
    Disease: Version SOC Term Classification Code Term Level
    9.1 10011796 Cystitis interstitial LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-004555-39 Sponsor Protocol Number: 3652-CL-0018 Start Date*: 2012-05-07
    Sponsor Name:Astellas Pharma Europe B.V.
    Full Title: A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel group, Adaptive, combined Proof of Concept and Dose-Finding study to investigate Efficacy, Safety, Pharmacodynamics and Pharmacokin...
    Medical condition: Bladder Pain Syndrome / Interstitial Cystitis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10038359 - Renal and urinary disorders 10071166 Bladder pain syndrome LLT
    14.1 10038359 - Renal and urinary disorders 10008928 Chronic interstitial cystitis NOS LLT
    14.1 10038359 - Renal and urinary disorders 10008927 Chronic interstitial cystitis LLT
    14.1 10038359 - Renal and urinary disorders 10011796 Cystitis interstitial PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed) NL (Completed) CZ (Completed) DE (Completed) LV (Completed) PT (Completed) ES (Completed) PL (Completed) DK (Completed) LT (Completed)
    Trial results: View results
    EudraCT Number: 2015-004495-30 Sponsor Protocol Number: CYCLOIC-1 Start Date*: 2015-12-14
    Sponsor Name:Oulu University Hospital
    Full Title: Safety of intravesical bladder instillations among patients with severe interstitial cystitis
    Medical condition: Interstitial cystitis and bladder pain syndrome
    Disease: Version SOC Term Classification Code Term Level
    18.1 10038359 - Renal and urinary disorders 10071166 Bladder pain syndrome LLT
    18.1 10038359 - Renal and urinary disorders 10011796 Cystitis interstitial PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2013-003327-11 Sponsor Protocol Number: 3623 Start Date*: 2015-02-10
    Sponsor Name:University of Southampton
    Full Title: Alternative Treatments of Adult female Urinary Tract Infection: a double blind, placebo controlled,factorial randomised trial of Uva ursi and open pragmatic trial of ibuprofen.
    Medical condition: Acute urinary tract infections.
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004862 10000698 Acute cystitis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-005706-11 Sponsor Protocol Number: Cyst2016_01 Start Date*: 2016-03-14
    Sponsor Name:Vita Green Europa S.A.
    Full Title: Single-site, open, randomized clinical trial to assess the non-inferiority of Cysticlean® versus Fosfomicina in the treatment of cystitis in women in Spain.
    Medical condition: Urinary Tract Infection (UTI)
    Disease: Version SOC Term Classification Code Term Level
    18.1 10021881 - Infections and infestations 10011790 Cystitis escherichia PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2018-001448-78 Sponsor Protocol Number: Cyst2018_01 Start Date*: 2018-11-08
    Sponsor Name:Vita Green Europa S.A.
    Full Title: Single-site, open, randomized clinical trial to assess the non-inferiority of Cysticlean® versus Fosfomicina in the treatment of cystitis in women in Spain.
    Medical condition: Urinary Tract Infection (UTI)
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10011790 Cystitis escherichia PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-003367-23 Sponsor Protocol Number: 672-CL-035 Start Date*: 2006-02-13
    Sponsor Name:Astellas Pharma Europe B.V.
    Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of YM672 in the Treatment of Painful Bladder Syndrome/Interstitial Cystitis
    Medical condition: Interstitial Cystitis / Painful Bladder Syndrome
    Disease: Version SOC Term Classification Code Term Level
    8.0 10008928 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) SE (Completed) DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-002421-37 Sponsor Protocol Number: A4291043 Start Date*: Information not available in EudraCT
    Sponsor Name:Pfizer Ltd., Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK
    Full Title: A PHASE 2, 12 WEEK, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL GROUP, PROOF OF CONCEPT STUDY EVALUATING THE EFFICACY AND SAFETY OF PD 0299685 FOR THE TREATMENT OF SYMPTOMS...
    Medical condition: INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008927 Chronic interstitial cystitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) DK (Completed) FR (Completed) FI (Completed)
    Trial results: View results
    EudraCT Number: 2010-022096-54 Sponsor Protocol Number: Repha_1344 Start Date*: 2011-04-04
    Sponsor Name:Repha GmbH
    Full Title: Randomised, prospective, double-dummy double-blinded study to evaluate safety and efficacy of Angocin Anti-Infekt N versus standard antibiotics in the treatment of acute uncomplicated cystitis
    Medical condition: Treatment of acute uncomplicated cystitis
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10011781 Cystitis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2020-000553-27 Sponsor Protocol Number: 212390 Start Date*: 2020-06-24
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin...
    Medical condition: Urinary Tract Infection (Acute Cystitis)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10011781 Cystitis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: BG (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2018-001801-98 Sponsor Protocol Number: 204989 Start Date*: 2020-02-27
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin...
    Medical condition: Urinary Tract Infection (Acute Cystitis)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10011781 Cystitis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) BG (Completed) GR (Completed) HU (Completed) CZ (Completed) SK (Completed) RO (Ongoing)
    Trial results: View results
    EudraCT Number: 2012-002776-14 Sponsor Protocol Number: 97 Start Date*: 2013-03-15
    Sponsor Name:University of Oslo, Faculty of medicine, Institute of Health and Society
    Full Title: Ibuprofen versus mecillinam for uncomplicated cystitis in adult, non-pregnant women
    Medical condition: Uncomplicated cystitis in adult, non pregnant women, age 18-60.
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004862 10000699 Acute cystitis (excl in pregnancy) LLT
    Population Age: Adults Gender: Female
    Trial protocol: NO (Completed) DK (Completed) SE (Completed)
    Trial results: View results
    EudraCT Number: 2009-014597-17 Sponsor Protocol Number: A4091035 Start Date*: 2010-05-03
    Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017
    Full Title: A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGING STUDY EVALUATING THE EFFICACY AND SAFETY OF TANEZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH INTERSTITIA...
    Medical condition: Chronic pain including the pain of interstitial cystitis/painful bladder syndrome.
    Disease: Version SOC Term Classification Code Term Level
    12.0 10008927 Chronic interstitial cystitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended) BE (Completed) ES (Prematurely Ended) DE (Prematurely Ended) FI (Completed) SK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-000906-12 Sponsor Protocol Number: AQX-1125-301 Start Date*: 2016-09-07
    Sponsor Name:Aquinox Pharmaceuticals (Canada) Inc.
    Full Title: The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3 Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targ...
    Medical condition: Interstitial Cystitis/Bladder Pain Syndrome
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004857 10071166 Bladder pain syndrome LLT
    20.0 100000004857 10008927 Chronic interstitial cystitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended) HU (Completed) CZ (Completed) LV (Prematurely Ended) GB (Prematurely Ended) BE (Completed) ES (Prematurely Ended) NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-001512-31 Sponsor Protocol Number: AM3/CISAP/04 Start Date*: 2004-09-28
    Sponsor Name:Industial Farmacéutica Cantabria S. A.
    Full Title: Evaluación del efecto de AM3 en el tratamiento de la cistitis recidivante de la mujer
    Medical condition: Treatment of the recurrent cystitis in women
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-004653-25 Sponsor Protocol Number: Repha_1362 Start Date*: 2014-05-02
    Sponsor Name:Repha GmbH
    Full Title: Clinical trial for examination of efficacy and safety of ANGOCIN® Anti-Infekt N versus placebo in the continous prophylaxis of chronically recurring uncomplicated cystitis
    Medical condition: Continuous prophylaxis of chronically recurring uncomplicated cystitis
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10011786 Cystitis chronic LLT
    21.1 10038359 - Renal and urinary disorders 10063057 Cystitis noninfective PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2009-018118-21 Sponsor Protocol Number: OXN2503 Start Date*: Information not available in EudraCT
    Sponsor Name:Mundipharma Research GmbH & Co. KG
    Full Title: An exploratory, randomised, double-blind, placebo-controlled, parallel group, pilot study to assess the analgesic efficacy of oxycodone/naloxone prolonged release tablets (OXN PR) compared to place...
    Medical condition: Bladder Pain Syndrome (BPS), formerly addressed as IC/PBS (interstitial cystitis /Painful Bladder Syndrome)
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004857 10008927 Chronic interstitial cystitis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed) HU (Completed) CZ (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-001486-15 Sponsor Protocol Number: TM-ME1207/311 Start Date*: 2007-08-02
    Sponsor Name:TEDEC-MEIJI FARMA, S.A.
    Full Title: Multicentre, prospective, comparative, randomized, double-blind, double-dummy study to assess the efficacy and safety of cefditoren pivoxil versus ciprofloxacin in acute uncomplicated cystitis. Est...
    Medical condition: Cistitis aguda no complicada en mujeres no embarazadas: patología caracterizada por disuria, dolor suprapúbico, polaquiuria y/o tenesmo en combinación con bacteriuria y piuria. Sin patología renal ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000699 Acute cystitis (excl in pregnancy) LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Completed) GR (Completed)
    Trial results: View results
    EudraCT Number: 2015-004297-14 Sponsor Protocol Number: SLH2015001 Start Date*: 2016-06-08
    Sponsor Name:Streeklaboratorium voor de volksgezondheid Kennemerland
    Full Title: Effectiveness of fosfomycin versus nitrofurantoin in Dutch risk groups with cystitis: a pilot study (Uri-weg study)
    Medical condition: Cystitis without tissue invasion (uncomplicated cytitis)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-000938-19 Sponsor Protocol Number: 4PH/2012/002 Start Date*: 2012-06-11
    Sponsor Name:NOVINTETHICAL PHARMA SAGL
    Full Title: Safety and Efficacy of tablets containing extract of Hibiscus Sabdariffa (HS) and Propoli versus placebo in the treatment of the cystitis with Ciproxin
    Medical condition: patients with diagnosys of cystitis confirmed by urine culture
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10021881 Infections and infestations SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 14 12:09:30 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA